Skip header and navigation

Narrow By

   MORE

1 records – page 1 of 1.

Golimumab (Simponi) therapy

https://libcat.nshealth.ca/en/permalink/chpams35651
Nova Scotia Health Authority. Central Zone. Division of Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1641
Available Online
View Pamphlet
Your healthcare provider feels that treatment with golimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Division of Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Golimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with golimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1641
Less detail